Research location
Busan
South Korea
Advertisement
Research activity in Busan
South KoreaCureCurrent currently publishes aggregate city-level research activity for this location: 458 trials and 686 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Busan
458 linked trials · page 4 of 10A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyNCT03499704 · 2020-02-11 · 2 site observations
COMPLETED
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerNCT04191499 · 2020-01-29 · 1 site observation
ACTIVE_NOT_RECRUITING
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNCT04129502 · 2020-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerNCT04077099 · 2020-01-07 · 1 site observation
ACTIVE_NOT_RECRUITING
T-DM1 in HER2-positive Metastatic/Relapsed Breast CancerNCT04202328 · 2019-12-19 · 5 site observations
UNKNOWN
Effect of Real-time Continuous Glucose Monitoring System in Overweight or Obese Adults With PrediabetesNCT04099550 · 2019-12-06 · 1 site observation
UNKNOWN
Study of DF1001 in Patients With Advanced Solid TumorsNCT04143711 · 2019-11-11 · 1 site observation
COMPLETED
Phase 2 Study of Dacomitinib in NSCLCNCT04027647 · 2019-09-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South KoreaNCT04592523 · 2019-09-05 · 1 site observation
COMPLETED
Comparison of OCTA Factors in Patients With or Without Amyloid Pathology: A Prospective StudyNCT05475158 · 2019-09-01 · 1 site observation
COMPLETED
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCNCT03997123 · 2019-06-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUSNCT03918304 · 2019-06-11 · 1 site observation
COMPLETED
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerNCT03871816 · 2019-04-22 · 1 site observation
COMPLETED
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseNCT03887455 · 2019-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)NCT03798054 · 2019-02-15 · 1 site observation
COMPLETED
The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PDNCT03227783 · 2019-02-01 · 1 site observation
UNKNOWN
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerNCT03748641 · 2019-01-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional TreatmentNCT03689244 · 2019-01-23 · 1 site observation
TERMINATED
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung CancerNCT03800134 · 2018-12-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBCNCT03562637 · 2018-12-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)NCT03713684 · 2018-11-09 · 1 site observation
TERMINATED
Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg DuvieNCT03770052 · 2018-10-24 · 1 site observation
COMPLETED
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03443973 · 2018-08-22 · 1 site observation
TERMINATED
Regulatory Request NIS in KoreaNCT03642717 · 2018-08-21 · 2 site observations
COMPLETED
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With SchizophreniaNCT03593213 · 2018-07-30 · 2 site observations
TERMINATED
A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.NCT03560336 · 2018-07-05 · 6 site observations
COMPLETED
Rheumatoid Arthritis Satisfaction Outcome ResearchNCT03703817 · 2018-07-02 · 2 site observations
COMPLETED
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World SettingNCT03448445 · 2018-06-22 · 2 site observations
COMPLETED
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)NCT03521934 · 2018-06-15 · 1 site observation
TERMINATED
Influence of Obesity on Microvascular Reactivity During General AnesthesiaNCT05829785 · 2018-06-01 · 1 site observation
COMPLETED
Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia PatientsNCT03839251 · 2018-06-01 · 1 site observation
COMPLETED
A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With OsimertinibNCT03239340 · 2018-05-30 · 1 site observation
COMPLETED
Effect of Efpeglenatide on Cardiovascular OutcomesNCT03496298 · 2018-04-27 · 1 site observation
TERMINATED
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid TumorsNCT03552406 · 2018-04-27 · 1 site observation
UNKNOWN
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)NCT03456063 · 2018-04-24 · 1 site observation
COMPLETED
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's DementiaNCT03441516 · 2018-04-19 · 6 site observations
UNKNOWN
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerNCT03519971 · 2018-03-29 · 1 site observation
COMPLETED
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-ANCT03447769 · 2018-03-16 · 1 site observation
TERMINATED
Role of Dopamine Transporter in Glucose ControlNCT03466697 · 2018-03-14 · 1 site observation
COMPLETED
A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in KoreaNCT03416855 · 2018-01-31 · 4 site observations
COMPLETED
A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer ParticipantsNCT03437083 · 2018-01-25 · 3 site observations
COMPLETED
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCNCT03326674 · 2017-12-21 · 1 site observation
TERMINATED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyNCT03315364 · 2017-12-18 · 3 site observations
ACTIVE_NOT_RECRUITING
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCNCT03395197 · 2017-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)NCT03232593 · 2017-11-29 · 9 site observations
COMPLETED
Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in KoreaNCT03271554 · 2017-11-09 · 5 site observations
COMPLETED
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate CancerNCT03261999 · 2017-09-26 · 1 site observation
COMPLETED
The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AINCT03369886 · 2017-09-25 · 1 site observation
UNKNOWN
Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real WorldNCT03264703 · 2017-09-11 · 4 site observations
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.